{"podcast":{"title":"Hematologic Oncology Update","slug":"hematologic-oncology-update-916423","podcast_index_feed_id":916423,"rss_url":"https://feeds.captivate.fm/hematologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/hematologic-oncology","image_url":"https://artwork.captivate.fm/385e0bc2-3e77-4650-a103-033cd89470e0/VM1-kJu7V4rmiKPVI6DGtcq3.png","author":"Dr. Neil Love","episode_count":145,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.","last_synced_at":"2026-07-10T00:19:38.916639+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423"},"episode":{"title":"CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients","slug":"car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients","published_at":"2025-12-11T19:30:00+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients","show_page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423","url":"https://hematologic-oncology.captivate.fm/episode/5559-patientproject2025-cartclinicians","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/f4aefd1c-ff3d-43a0-a133-7d2501c8dd40.mp3","summary":"Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discuss the clinical applications of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma.&nbsp;&nbsp;&nbsp; CME information and select publications here .","meta_description":"Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discu…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3510,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}